Single-cell Omics: Emerging Technologies and Markets

Report Scope:

The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.

The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Report Includes:

43 data tables and 59 additional tables

An overview of the global markets and emerging technologies for single-cell genomics and proteomics

Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region

Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification

Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics

Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years

Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology

A discussion of the industry’s ESG challenges and practices

Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages

Insight into industry structure, competitive landscape, clinical trials and ongoing research activity

Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA

Companies Mentioned

10x Genomics
Agilent Technologies Inc.
Bd
Bio-rad Laboratories Inc.
Bio-techne
Bruker
F. Hoffmann-la Roche Ltd.
Illumina Inc.
Merck Kgaa
Promega Corp.
Qiagen
Sartorius Ag
Standard Biotools
Tecan Trading Ag
Thermo Fisher Scientific Inc.